Our “off-the-shelf” supply of mesenchymal stem cells (MSCs) have been used for viral therapy applications outside of cancer treatment, including in contribution to the treatment of COVID-19.

Our Technology

Pre-clinical data has shown our SNV1 product to shield the oncolytic virus from a patient’s immune system, supporting efficient delivery to tumor sites and effectively potentiating the viral payload.

Calidi’s years of research into the powerful therapeutic effects of stem cells have revealed exciting and groundbreaking implications for the treatment of cancer and other therapy-resistant diseases.

Learn More

Our Team

A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.

Executives talking about business sitting on a bench